Abstract
Oseltamivir is the most common antiviral drug used to treat and prevent influenza. Epidemiological studies performed in Japan, the United States, and the United Kingdom indicate that oseltamivir may cause psychiatric symptoms; however, the underlying mechanism has not been elucidated. In South Korea, interest in oseltamivir has increased with the spread of the new influenza virus; however, no case report or investigation of psychiatric symptoms associated with the drug has been reported to date. Here, we report a case of a 22-year-old male who complained of mood swings, suicidal feelings, auditory hallucinations, memory deterioration, and insomnia after taking oseltamivir.
| Original language | English |
|---|---|
| Pages (from-to) | 209-211 |
| Number of pages | 3 |
| Journal | Clinical Psychopharmacology and Neuroscience |
| Volume | 13 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2015 Aug 1 |
Keywords
- Human influenza
- Oseltamivir
- Psychiatric symptom
- Side effect
- Tamiflu
ASJC Scopus subject areas
- Psychiatry and Mental health
- Behavioral Neuroscience
- Pharmacology (medical)
Fingerprint Dive into the research topics of 'Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report'. Together they form a unique fingerprint.
Cite this
Jeon, S. W., & Han, C. (2015). Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report. Clinical Psychopharmacology and Neuroscience, 13(2), 209-211. https://doi.org/10.9758/cpn.2015.13.2.209